Trends in treatment for pancreatic cancer

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 8, Issue 6, 2001, Pages 544-548

  Matsuno, Seiki ^a   Egawa, Shinichi ^a   Arai, Kosuke ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemoradiation; Pancreatectomy; Pancreatic cancer

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; GENE THERAPY; HUMAN; IMMUNOTHERAPY; JEJUNOSTOMY; METHODOLOGY; MORTALITY; MULTIMODALITY CANCER THERAPY; PAIN; PALLIATIVE THERAPY; PANCREAS TUMOR; PANCREATICODUODENECTOMY; QUALITY OF LIFE; REVIEW;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; GENE THERAPY; HUMANS; IMMUNOTHERAPY; JEJUNOSTOMY; PAIN; PALLIATIVE CARE; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; QUALITY OF LIFE; RADIOTHERAPY, ADJUVANT;

EID: 0035750658     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005340100023     Document Type: Review

References (30)

1. Sener SF, Fremgen A, Menck HR, Winchester DP (1999) Pancreatic cancer: a report of treatment and survival trends for 100313 patients diagnosed from 1985 to 1995, using the National Cancer Database. J Am Coll Surg 189:1-7
2. Evans DB, Pisters PW, Lee JE, Bold RJ, Charnsangavej C, Janjan NA, Wolff RA, Abbruzzese JL (1998) Preoperative chemoradiation strategies for localized adenocarcinoma of the pancreas. J Hepatobiliary Pancreat Surg 5:242-250
3. Pendurthi TK, Hoffman JP, Ross E, Johnson DE, Eisenberg BL (1998) Preoperative versus postoperative chemoradiation for patients with resected pancreatic adenocarcinoma. Am Surg 64:686-692
4. Wanebo HJ, Glicksman AS, Vezeridis MP, Clark J, Tibbetts L, Koness RJ, Levy A (2000) Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer Arch Surg 135:81-87
5. White R, Lee C, Anscher M, Gottfried M, Wolff R, Keogan M, Pappas T, Hurwitz H, Tyler D (1999) Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas. Ann Surg Oncol 6:38-45
6. Pisters PW, Abbruzzese JL, Janjan KA, Cleary KR, Charnsangavej C, Goswitz MS, Rich TA, Raijman I, Wolff RA, Lenzi R, Lee JE, Evans DB (1998) Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma. J Clin Oncol 16:3843-3850
7. Bajetta E, Di Bartolomeo M, Stani SC, Artale S, Ricci SB, Bozzetti F, Mazzaferro V, Toffolatti L, Buzzoni R (1999) Chemoradiotherapy as preoperative treatment in locally advanced unresectable pancreatic cancer patients: results of a feasibility study. Int J Radiat Oncol Biol Phys 45:285-289
8. Nagakawa T, Konishi I, Ueno K, Ohta T, Kayahara M, Miyazaki I (1998) Extended radical pancreatectomy for carcinoma of the head of the pancreas. Hepatogastroenterology 45:849-854
9. Iacono C, Facci E, Bortolasi L, Zamboni G, Scarpa A, Talamini G, Prati G, Nifosi F, Serio G (1999) Intermediate results of extended pancreaticoduodenectomy. Verona experience. J Hepatobiliary Pancreat Surg 6:74-78
10. Mukaiya M, Hirata K, Satoh T, Kimura M, Yamashiro K, Ura H, Oikawa I, Denno R (1998) Lack of survival benefit of extended lymph node dissection for ductal adenocarcinoma of the head of the pancreas: retrospective multi-institutional analysis in Japan. World J Surg 22:248-253
11. Yeo CJ, Cameron JL, Sohn TA, Coleman J, Sauter PK, Hruban RH, Pitt HA, Lillemoe KD (1999) Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg 229:613-624
12. Pedrazzoli S, DiCarlo V, Dionigi R, Mosca F, Pederzoli P, Pasquali C, Klöppel G, Dhaene K, Michelassi F (1998) Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg 228:508-517
13. Leach SD, Lee JE, Charnsangavej C, Cleary KR, Lowy AM, Fenoglio CJ, Pisters PW, Evans DB (1998) Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head. Br J Surg 85:611-617
14. Sohn TA, Lillemoe KD, Cameron JL, Huang JJ, Pitt HA, Yeo CJ (1999) Surgical palliation of unresectable periampullary adenocarcinoma in the 1990s. J Am Coll Surg 188:658-669
15. Lillemoe KD, Cameron JL, Hardacre JM, Sohn TA, Sauter PK, Coleman J, Pitt HA, Yeo CJ (1999) Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg 230:322-330
16. Röthlin MA, Schöb O, Weber M (1999) Laparoscopic gastro- and hepaticojejunostomy for palliation of pancreatic cancer: a case controlled study. Surg Endosc 13:1065-1069
17. Tham TC, Lichtenstein DR, Vandervoort J, Wong RC, Slivka A, Banks PA, Yim HB, Carr-Locke DL (2000) Pancreatic duct stents for "obstructive type" pain in pancreatic malignancy. Am J Gastroenterol 95:956-960
18. Pietrabissa A, Vistoli F, Carobbi A, Boggi U, Bis'a M, Mosca F (2000) Thoracoscopic splanchnicectomy for pain relief in unresectable pancreatic cancer. Arch Surg 135:332-335
19. Glimelius B (1998) Chemotherapy in the treatment of cancer of the pancreas. J Hepatobiliary Pancreat Surg 5:235-241
20. Beger HG, Gansauge F, Büchler MW, Link KH (1999) Intraarterial adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic cancer: significant reduction in occurrence of liver metastasis. World J Surg 23:946-949
21. Klinkenbijl JH, Jeekel J, Sahmoud T, van Pel R, Couvreur ML, Veenhof CH, Arnaud JP, Gonzalez DG, de Wit LT, Hennipman A, Wils J (1999) Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC Gastrointestinal Tract Cancer Cooperative Group. Ann Surg 230:776-784
22. Kornek GV, Schratter-Sehn A, Marczell A, Depisch D, Karner J, Krauss G, Haider K, Kwasny W, Locker G, Scheithauer W (2000) Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin. Br J Cancer 82:98-103
23. Storniolo AM, Enas NH, Brown CA, Voi M, Rothenberg ML, Schilsky R (1999) An investigational new drug treatment program for patients with gemcitabine: results tor over 3000 patients with pancreatic carcinoma. Cancer 85:1261-1268
24. Okada S, Sakata Y, Matsuno S, Kurihara M, Sasaki Y, Ohashi Y, Taguchi T (1999) Phase II study of docetaxel in patients with metastatic pancreatic cancer: a Japanese cooperative study. Cooperative Group of Docetaxel for Pancreatic Cancer in Japan. Br J Cancer 80:438-443
25. Cascinu S, Frontini L, Comella G, Barni S, Labianca R, Battelli N, Casaretti R, Zonato S, Pirovano M, Catalano G, Cellerino R (1999) Intensive weekly chemotherapy is not effective in advanced pancreatic cancer patients: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). Br J Cancer 79:491-494
26. Fitzsimmons D, Johnson CD, George S, Payne S, Sandberg AA, Bassi C, Beger HG, Birk D, Büchler MW, Dervenis C, Fernandez Cruz L, Friess H, Grahm AL, Jeekel J, Laugier R, Meyer D, Singer MW, Tihanyi T (1999) Development of a disease-specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life. Eur J Cancer 35:939-941
27. Chang KJ, Nguyen PT, Thompson JA, Kurosaki TT, Casey LR, Leung EC, Granger GA (2000) Phase I clinical trial of allogeneic mixed lymphocyte culture (cytoimplant) delivered by endoscopic ultrasound-guided fine-needle injection in patients with advanced pancreatic carcinoma. Cancer 88:1325-1335
28. Nukui Y, Picozzi VJ, Traverso LW (2000) Interferon-based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am J Surg 179:367-371
29. Scheithauer W, Kornek GV, Raderer M, Hejna M, Valencak J, Miholic J, Kovats E, Lang F, Funovics J, Bareck E, Depisch D (1999) Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma. Br J Cancer 80:1797-1802
30. Motoi F, Sunamura M, Ding L, Duda DG, Yoshida Y, Zhang W, Matsuno S, Hamada H (2000) Effective gene therapy for pancreatic cancer by cytokines mediated by restricted replication-competent adenovirus. Hum Gene Ther 11:223-235